Literature DB >> 455888

Lorcainide. II. Plasma concentration-effect relationship.

T Meinertz, W Kasper, F Kersting, H Just, H Bechtold, E Jähnchen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 455888     DOI: 10.1002/cpt1979262196

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  11 in total

1.  Lorcainide treatment of Wolff-Parkinson-White syndrome in children and adolescents.

Authors:  M Samánek; V Hrobonová; H Bartáková
Journal:  Pediatr Cardiol       Date:  1987       Impact factor: 1.655

Review 2.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

3.  Bioavailability and saturation of the presystemic metabolism of oral lorcainide therapy initiated in three different dose regimens.

Authors:  W K Amery; J Heykants; K Bruyneel; R Terryn
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 4.  Adverse effects of antiarrhythmic drugs.

Authors:  J B Schwartz; D Keefe; D C Harrison
Journal:  Drugs       Date:  1981-01       Impact factor: 9.546

5.  The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration--effect relationships.

Authors:  N H Holford; P E Coates; T W Guentert; S Riegelman; L B Sheiner
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

Review 6.  Lorcainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  C e Eiriksson; R N Brogden
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

Review 7.  Clinical pharmacokinetics of the newer antiarrhythmic agents.

Authors:  A M Gillis; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

Review 8.  First-pass elimination. Basic concepts and clinical consequences.

Authors:  S M Pond; T N Tozer
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

Review 9.  Individual variation in first-pass metabolism.

Authors:  Y K Tam
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

10.  Haemodynamic effects of a single intravenous dose of lorcainide in patients with heart disease.

Authors:  T Meinertz; F Kersting; W Kasper; H Just; H Bechtold; E Jähnchen
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.